Molecular Diagnostics
Association Found Between MC1R Variant and Melanoma Risk
A new study finds that melanocortin-1 receptor is a risk factor for melanoma independent of sun exposure, supporting recent mouse model research that showed a UV radiation-independent pathway for development of melanoma and highlighting the importance of the genetic background of the host. More...12 Apr 2016
Prostate Needle Biopsy Biomarker Predicts Tumor Aggressiveness
A new study demonstrates the ability to measure and evaluate biomarkers from ribonucleic acid expression data obtained from prostate needle biopsies. The data demonstrate a high concordance in the genomic signatures between needle biopsy samples and post-prostatectomy tissue samples. More...11 Apr 2016
Gene Test Identifies Patients with High Risk Colon Cancer
Proprietary microarray-based gene signature marker can identify patients' recurrence risk within five years after surgery and guides adjuvant chemotherapy treatment decisions. Colon cancer is the second leading cause of cancer mortality among men and women in the USA and the five-year survival rate for individuals with colon cancer is 64.9%. More...11 Apr 2016
Improved “Liquid Biopsy” Technique Enhances Tumor DNA Detection
An improved method has been devised to significantly increase the sensitivity of a technique to identify and sequence DNA from cancer cells circulating in a person's blood. The hope is that such "liquid biopsies" of easily obtained blood samples could one day replace the need to surgically obtain tumor tissue for examination. More...10 Apr 2016
Noncoding RNA Gene Linked to Malignant Melanoma
While a large share of the human genome has long been considered “junk DNA” because it does not contribute to protein coding, recent insights indicate that it does produce many noncoding ribonucleic acids that play important roles in essential biological processes and diseases. More...05 Apr 2016
New
Gold Member
Latex Test
SLE-Latex Test
New
PSA Assay
CanAg PSA EIA
New
Pan-Cancer Panel
TruSight Oncology 500
In Other News
Novel Blood Test Detects Colorectal Cancer Recurrence Earlier
Hereditary Cancer Test Identifies Deleterious Mutations in Endometrial Cancer
Multigene Test Identifies Early Breast Cancer
Blood Test Gives Early Warning of Melanoma Relapse
Robust Method Developed for Microbiome Analysis
Biomarker Identifies Uveal Melanoma Patients at Risk for Metastasis
Ultrasensitive Antibody Detection Enabled by Agglutination-PCR
Whole-Exome Sequencing Identifies Rare Inherited Diseases
Gene Predicts Outcomes for Head and Neck Patients
Genomic Analyses Identifies Molecular Subtypes of Pancreatic Cancer
Biomarkers Help Diagnose Mild Cognitive Impairment in Diabetics
New Protocol Rapidly Detects Three Legionella Species
Blood Test Developed to Detect Five Early-Stage Cancers
Blood Test Detects All Known Inherited Heart Conditions Genes
Tumor Biopsies with Blood Monitoring Show Lesion-Specific Response
Molecular Type 2 Diabetes Biomarker Identified
Nanotechnology Helps Detects Biomarkers of Cancer
Gene Mutation Provides Clue to Vibratory Urticaria
Fast and Accurate Cystic Fibrosis Test Developed for Newborns
Listeria Hypervirulence Uncovered by Harnessing Its Biodiversity
Prognostic Biomarker Found for Colon Cancer Patients
Blood Test Improves Treatment for Acute Myeloid Leukemia
Aberrant Gene Expression Predicts Metastatic Endometrial and Lung Cancers
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
